Methicillin-resistant Staphylococcus aureus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

Clin Transplant. 2019 Sep;33(9):e13611. doi: 10.1111/ctr.13611. Epub 2019 Jun 20.


These updated guidelines from the American Society of Transplantation Infectious Diseases Community of Practice review the epidemiology, diagnosis, prevention, and management of methicillin-resistant Staphylococcus aureus (MRSA) infections in solid organ transplantation. Despite an increasing armamentarium of antimicrobials active against MRSA, improved diagnostic tools, and overall declining rates of infection, MRSA infections remain a substantial cause of morbidity and mortality in solid organ transplant recipients. Pre- and post-transplant MRSA colonization is a significant risk factor for post-transplant MRSA infection. The preferred initial treatment of MRSA bacteremia remains vancomycin. Hand hygiene, chlorhexidine bathing in the ICU, central-line bundles that focus on reducing unnecessary catheter use, disinfection of patient equipment, and the environment along with antimicrobial stewardship are all aspects of an infection prevention approach to prevent MRSA transmission and decrease healthcare-associated infections.

Keywords: Methicillin-resistant Staphylococcus aureus; bacteremia; pneumonia; prevention; solid organ transplantation; treatment.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use*
  • Humans
  • Methicillin-Resistant Staphylococcus aureus / isolation & purification*
  • Organ Transplantation / adverse effects*
  • Practice Guidelines as Topic / standards*
  • Societies, Medical
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / drug therapy*
  • Staphylococcal Infections / etiology
  • Transplant Recipients


  • Anti-Bacterial Agents